Objectives:
The analysis aims to present the subjective assessment of the MoodMon mobile application by users diagnosed with BD and MDD.

Methods:
Data were obtained from 95 participants based on a 12-question survey. It was a part of a large clinical study of the MoodMon system.

Results:
The reception of the MoodMon application was very similar regardless of the diagnosis. For most respondents, the application was a neutral tool (BD – 50.7%; MDD – 43.5%). Subjective satisfaction with using the application was reported by most users. The application was beneficial for 56.9% of respondents with BD and 78.3% with MDD disorders, primarily due to the ability to use modern technology to control symptoms. Most respondents did not see the need for changes to the application (BD – 70.8%; MDD – 60.9%). However, a small group suggested modifications to the form of voice sampling and the variety of questions. Nearly half of the patients with BD (48.6%) expressed a willingness to use the MoodMon application in the future, and a significantly higher percentage (73.9%) of those with MDD indicated the same.

Conclusions:
In the subjective opinion of users, the MoodMon application is perceived as safe, useful and helpful in the treatment of affective disorders.